72
51. Ley SJ, William RC Jr. A family with hereditary angioedema
and multiple immunologic disorders.
Am J Med.
1987;82:1046-1051.
52. Agnello V. Association of systemic lupus erythematosus
and SLE-like syndromes with hereditary and acquired
complement deficiency states.
Arthritis Rheum.
1978;21(suppl 5):S146-S152.
53. Suzuki Y, Nihei H, Mimura N, et al. A case of hereditary
angioneurotic edema associated with systemic lupus
erythematosus.
Jpn J Med.
1986;25:281-287.
54. Suzuki Y, Hinoshita F, Yokoyama K, et al. Association
of Sjögren’s syndrome with hereditary angioneurotic
edema: report of a case.
Clin Immunol Immunopathol.
1997;84:95-97.
55. Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and
estimated population burden of selected autoimmune
diseases in the United States.
Clin Immunol Immunopathol.
1997;84:223-243.
56. Williamson DM. Reticulate erythema – a prodrome in
hereditary angio-oedema.
Br J Dermatol.
1979;101:549-
552.
57. Farkas H, Harmat G, Fáy A, et al. Erythema marginatum
preceding an acute oedematous attack of hereditary
angioneurotic oedema.
Acta Derm Venereol.
2001;
81:376-377.
58. Gibbs JG, Craig TJ. Prodromal symptoms before
exacerbations of hereditary angioedema.
J Allergy Clin
Immunol.
2007;119:S278.
59. Kemp JG, Gibbs JG, Craig TJ. Variability of prodromal signs
and symptoms associated with hereditary angioedema
exacerbations.
J Allergy Clin Immunol.
2008;121:S100.
60. Prematta MJ, Kemp JG, Gibbs JG, et al. Frequency,
timing, and type of prodromal symptoms associated with
hereditary angioedema attacks.
Allergy Asthma Proc.
2009;30(5):506-511.
61. Byrd JB, Adam A, Brown NJ. Angiotensin-converting
enzyme inhibitor-associated angioedema.
Immunol
Allergy Clin N Am.
2006;26:725-737.
62. Longhurst HJ, Bork K. Hereditary angioedema: causes,
manifestations and treatment.
Br J Hosp Med.
2006;
67:654-657.
63. Wilson DA, Bork K, Shea EP, et al. Economic costs
associated with acute attacks and long-termmanagement
of hereditary angioedema.
Ann Allergy Asthma Immunol.
2010;104(4):314-320.
64. Lumry WR, Castaldo AJ, Vernon MK, et al. The humanistic
burden of hereditary angioedema: Impact on health-
related quality of life, productivity, and depression.
Allergy
Asthma Proc.
2010;31(5):407-414.
65. Bowie KJ, Scarupa MD, Li HH. Unnecessary abdominal
surgeries secondary to undiagnosed hereditary angio-
edema.
J Allergy Clin Immunol.
2007;119:S276.
66. Bygum A. Self-administration of intravenous C1-inhibitor
therapy for hereditary angioedema and associated quality
of life benefits.
Eur J Dermatol.
2009;19(2):147-151.
67. Cicardi M, Bork K, Caballero T, et al. Evidence-based
recommendations for therapeutic management of
angioedema owing to hereditary C1 inhibitor deficiency:
consensus report of an International Working Group.
Allergy.
2011;67(2):147-157.
68. Longhurst H, Farkas H, Craig T, et al. HAE international
home therapy consensus document.
Allergy Asthma Clin
Immunol.
2010;6(1):22.
69. Wahn V, Aberer W, Eberl W, et al. Hereditary angio-
edema (HAE) in children and adolescents – a consensus on
therapeutic strategies.
Eur J Pediatr.
2012;171(9):1339-
1348.
70. Caballero T, Farkas H, Bouillet L, et al. International
consensus and practical guidelines on the gynecologic and
obstetric management of female patients with hereditary
angioedema caused by C1 inhibitor deficiency.
J Allergy
Clin Immunol.
2012;129(2):308-320.
71. Craig T, Pürsün EA, Bork K, et al. WAO guideline for the
management of hereditary angioedema.
World Allergy
Organ J.
2012;5(12):182-199.
72. Czaller I, Visy B, Csuka D, et al. The natural history of
hereditary angioedema and the impact of treatment
with human C1-inhibitor concentrate during pregnancy:
a long-term survey.
Eur J Obstet Gynecol Reprod Biol.
2010;152(1):44-49.
73. Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, et al.
Characterization of acute hereditary angioedema attacks
during pregnancy and breast-feeding and their treatment
with C1 inhibitor concentrate.
Am J Obstet Gynecol.
2010;203(2):131.e1-7.
74. Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, et al.
Pharmacokinetic analysis of human plasma-derived
pasteurized C1-inhibitor concentrate in adults and
children with hereditary angioedema: a prospective study.
Transfusion.
2010;50(2):354-360.
